Phase 2b Study of EVO756 in Adults With Moderate to Severe Chronic Spontaneous Urticaria (CSU)
Trial details
- Registry ID
- NCT06873516
- Phase
- Phase 2
Drug identity checked against registry records
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| Phase 2b Study of EVO756 in Adults With Moderate to Severe Chronic Spontaneous Urticaria (CSU)NCT06873516 | EVMN | Phase 2 | Completed | 2026-05-29Actual |
| Phase 2b Study of EVO756 in Adults With Atopic DermatitisNCT07150845 | EVMN | Phase 2 | Completed | 2026-07-23Actual |
| No regulatory events match this view.This does not mean no FDA events have occurred. |